{
    "clinical_study": {
        "@rank": "43650", 
        "arm_group": [
            {
                "arm_group_label": "Therapeutic CPAP", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients continue therapeutic continuous positive airway pressure (CPAP)."
            }, 
            {
                "arm_group_label": "Subtherapeutic CPAP", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo-CPAP device delivering subtherapeutic pressure for two weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "Clinical trial in patients with obstructive sleep apnoea that are randomised to either\n      continue or withdraw continuous positive airway pressure therapy to identify a\n      disease-specific exhaled breath pattern by mass spectrometry."
        }, 
        "brief_title": "Breath Analysis in Obstructive Sleep Apnoea", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Obstructive Sleep Apnoea (OSA)", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Randomised placebo-controlled trial (therapeutic vs. subtherapeutic continuous positive\n      airway pressure [CPAP]) including 30 OSA patients to define the effects of CPAP withdrawal\n      (subtherapeutic CPAP) on the composition of exhaled breath analysed by mass spectrometry for\n      identification of OSA specific markers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Confirmed OSA (at the time of original diagnosis) with an oxygen desaturation index\n             (ODI) of >20/h.\n\n          -  Currently >20/h oxygen desaturations (\u22654% dips) during an ambulatory nocturnal pulse\n             oximetry performed on the last night of a 4-night period without CPAP.\n\n          -  Treated with CPAP for more than 12 months, minimum compliance 4h/night,\n             apnoea-hypopnoea index (AHI) <10 with treatment (according to CPAP- download) and\n             current ESS <10.\n\n          -  Age between 20 and 75 years at trial entry.\n\n        Exclusion Criteria:\n\n          -  Previous ventilatory failure (awake SpO2 <93% and PaCO2>6kPa).\n\n          -  Unstable, untreated coronary or peripheral artery disease, severe arterial\n             hypertension or hypotension  (>180/110 or <90/60mmHg)\n\n          -  Previously diagnosed with Cheyne-Stokes breathing.\n\n          -  Current professional driver; any previous sleep related accident.\n\n          -  Acute inflammatory disease.\n\n          -  Acute or chronic hepatic disease.\n\n          -  Renal failure or renal replacement therapy.\n\n          -  Use of inhaled drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02050425", 
            "org_study_id": "KEK-2013-0536"
        }, 
        "intervention": [
            {
                "arm_group_label": "Subtherapeutic CPAP", 
                "description": "short-term CPAP withdrawal by the use of Placebo-CPAP", 
                "intervention_name": "Placebo-CPAP device", 
                "intervention_type": "Device", 
                "other_name": "subtherapeutic CPAP"
            }, 
            {
                "arm_group_label": "Therapeutic CPAP", 
                "description": "Patients continue therapeutic CPAP therapy", 
                "intervention_name": "CPAP", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "OSA", 
            "CPAP", 
            "exhaled breath"
        ], 
        "lastchanged_date": "January 29, 2014", 
        "location": {
            "contact": {
                "email": "malcolm.kohler@usz.ch", 
                "last_name": "Malcolm Kohler, Prof. MD", 
                "phone": "+4144255111"
            }, 
            "contact_backup": {
                "email": "estherirene.schwarz@usz.ch", 
                "last_name": "Esther I Schwarz, MD", 
                "phone": "+4144255111"
            }, 
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "zip": "8091"
                }, 
                "name": "Division of Pulmonology, University Hospital Zurich"
            }, 
            "investigator": [
                {
                    "last_name": "Malcolm Kohler, Prof. MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Esther I Schwarz, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Exhaled Breath Analysis by Mass Spectrometry in Patients With Obstructive Sleep Apnoea - a Randomised Placebo-controlled Trial.", 
        "overall_contact": {
            "email": "malcolm.kohler@usz.ch", 
            "last_name": "Malcolm Kohler, Prof. MD", 
            "phone": "+41442551111"
        }, 
        "overall_contact_backup": {
            "email": "estherirene.schwarz@usz.ch", 
            "last_name": "Esther I Schwarz, MD", 
            "phone": "+41442551111"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "OSA-specific mass spectrometric exhaled breath pattern.", 
            "measure": "Exhaled breath pattern.", 
            "safety_issue": "No", 
            "time_frame": "at baseline and at follow-up (2 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02050425"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Zurich", 
            "investigator_full_name": "Malcolm Kohler", 
            "investigator_title": "Prof. Dr. med.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "measure of sleep apnoea severity", 
                "measure": "apnoea-hypopnoea index (AHI)", 
                "safety_issue": "No", 
                "time_frame": "at baseline and at follow-up (2 weeks)"
            }, 
            {
                "description": "measure of sleep apnoea severity", 
                "measure": "oxygen desaturation index (ODI), 4% dips", 
                "safety_issue": "No", 
                "time_frame": "at baseline and at follow-up (2 weeks)"
            }
        ], 
        "source": "University of Zurich", 
        "sponsors": {
            "collaborator": {
                "agency": "Swiss National Science Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}